Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
781
-
Total 13F shares, excl. options
-
268,204,669
-
Shares change
-
-7,507,151
-
Total reported value, excl. options
-
$10,811,195,153
-
Value change
-
-$297,360,231
-
Put/Call ratio
-
57.96%
-
Number of buys
-
278
-
Number of sells
-
-357
-
Price
-
$40.31
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q2 2018
859 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q2 2018.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 781 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 268,204,669 shares
.
Largest 10 shareholders include DODGE & COX (48,158,337 shares), ROYAL BANK OF CANADA (20,965,900 shares), FMR LLC (18,753,553 shares), PRICE T ROWE ASSOCIATES INC /MD/ (16,676,833 shares), Fisher Asset Management, LLC (13,824,123 shares), STATE STREET CORP (10,000,022 shares), RENAISSANCE TECHNOLOGIES LLC (9,329,400 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8,371,950 shares), BANK OF AMERICA CORP /DE/ (7,700,179 shares), and WELLS FARGO & COMPANY/MN (6,806,494 shares).
This table shows the top 781 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.